ABBV vs FIG · P/E 81, rev $61.16B vs rev $274.2M
AbbVie Inc (ABBV) versus Figma, Inc. (FIG) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Figma, Inc. (FIG) is a software - application company listed on NYSE.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported FIG revenue for 2025-09-30 was $274.2M. Net income was -$1.10B. Revenue was up 9.8% from 2025-06-30 to 2025-09-30. FIG currently screens at market cap $9.56B.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. FIG currently screens at market cap $9.56B.
Not investment advice. Open the ABBV and FIG stock pages for the full models.
Not investment advice.